Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B ‐cell acute lymphoblastic leukemia: A report from The Cytometry Society, India
Prashant Tembhare, Kunal Sehgal, Karthik Bommannan, Khaliqur Rahman et autres
Measurable residual disease (MRD) assessment is a key determinant of risk stratification and treatment modification in B-cell acute lymphoblastic leukemia (B-ALL). Multicolour flow cytometry (MFC) is a globally adopted rapid and sensitive MRD technique. However, technical practices remain significantly variable across laboratories, …
in, es, ru, Égypte, au (code pays fourni par la source)
0 citations
Cytometry Part B Clinical Cytometry